VCYT logo

Veracyte (VCYT) CAPEX

Annual CAPEX

$9.96 M
+$1.41 M+16.52%

December 31, 2023

Summary

Performance

1-Year Change

+16.52%

3-Year Change

+251.11%

5-Year Change

+431.54%

15-Year Change

+467.58%

VCYT CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.64%
VCYT annual capital expenditures is higher than 65.64% of companies in Healthcare sector

High & Low

All-time High

$9.96 M
VCYT annual capital expenditures is currently at an all-time high

3-Year Low

$5.38 M
VCYT annual capital expenditures is currently +85.29% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VCYT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
VCYT next annual earnings announcement is scheduled for Feb 21, 2025

OtherVCYTcash flowmetrics:

Annual FCF

$34.26 M
VCYT annual free cash flow is $34.26 million

Annual CFO

$44.22 M
VCYT annual cash flow from operations is $44.22 million

Annual CFI

$15.11 M
VCYT annual cash flow from investing activities is $15.11 million

Annual CFF

$2.84 M
VCYT annual cash flow from financing activities is $2.84 million

Quarterly CAPEX

$2.24 M
-$528.00 K-19.06%

September 30, 2024

Summary

Performance

3-Month Change

-19.06%

1-Year Change

-10.21%

3-Year Change

+23.73%

5-Year Change

+866.38%

VCYT Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.15%
VCYT quarterly capital expenditures is higher than 65.15% of companies in Healthcare sector

High & Low

All-time High

$4.19 M
VCYT quarterly capital expenditures is currently -46.49% below its historical high of $4.19 million

3-Year Low

$841.00 K
VCYT quarterly capital expenditures is currently +166.59% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VCYT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
VCYT next earnings announcement is scheduled for Feb 21, 2025

OtherVCYTcash flowmetrics:

Quarterly FCF

$27.72 M
VCYT quarterly free cash flow is $27.72 million

Quarterly CFO

$29.96 M
VCYT quarterly cash flow from operations is $29.96 million

Quarterly CFI

-$2.24 M
VCYT quarterly cash flow from investing activities is -$2.24 million

Quarterly CFF

$10.29 M
VCYT quarterly cash flow from financing activities is $10.29 million

TTM CAPEX

$9.64 M
-$560.00 K-5.49%

September 30, 2024

Summary

Performance

3-Month Change

-5.49%

1-Year Change

-3.19%

3-Year Change

+77.82%

5-Year Change

+249.89%

VCYT TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

64.26%
VCYT TTM capital expenditures is higher than 64.26% of companies in Healthcare sector

High & Low

All-time High

$11.10 M
VCYT TTM capital expenditures is currently -13.14% below its historical high of $11.10 million

3-Year Low

$5.38 M
VCYT TTM capital expenditures is currently +79.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VCYT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
VCYT next earnings announcement is scheduled for Feb 21, 2025

OtherVCYTcash flowmetrics:

TTM FCF

$56.48 M
VCYT TTM free cash flow is $56.48 million

TTM CFO

$66.12 M
VCYT TTM cash flow from operations is $66.12 million

TTM CFI

-$4.63 M
VCYT TTM cash flow from investing activities is -$4.63 million

TTM CFF

$10.06 M
VCYT TTM cash flow from financing activities is $10.06 million

VCYT CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.5%-10.2%-3.2%
3 y3 years+251.1%+23.7%+77.8%
5 y5 years+431.5%+866.4%+249.9%

VCYT CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+85.3%-38.9%+166.6%-13.1%+79.4%
5 y5-yearat high+261.4%-38.9%+253.1%-13.1%+264.4%
alltimeall timeat high+3509.1%-46.5%+1884.1%-13.1%+1634.3%

Veracyte CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.24 M(-19.1%)
$9.64 M(-5.5%)
Jun 2024
-
$2.77 M(+29.8%)
$10.20 M(-8.1%)
Mar 2024
-
$2.13 M(-14.5%)
$11.10 M(+11.5%)
Dec 2023
$9.96 M(+16.5%)
$2.50 M(-10.9%)
$9.96 M(+6.7%)
Sep 2023
-
$2.80 M(-23.6%)
$9.34 M(+13.2%)
Jun 2023
-
$3.67 M(+269.5%)
$8.25 M(+16.3%)
Mar 2023
-
$993.00 K(-47.0%)
$7.09 M(-17.1%)
Dec 2022
$8.55 M(+59.0%)
$1.87 M(+9.2%)
$8.55 M(+13.7%)
Sep 2022
-
$1.71 M(-31.7%)
$7.52 M(-1.3%)
Jun 2022
-
$2.51 M(+2.3%)
$7.62 M(+14.8%)
Mar 2022
-
$2.45 M(+191.7%)
$6.63 M(+23.4%)
Dec 2021
$5.38 M(+89.5%)
$841.00 K(-53.6%)
$5.38 M(-0.9%)
Sep 2021
-
$1.81 M(+18.7%)
$5.42 M(+27.7%)
Jun 2021
-
$1.53 M(+27.7%)
$4.25 M(+26.1%)
Mar 2021
-
$1.20 M(+34.7%)
$3.37 M(+18.7%)
Dec 2020
$2.84 M(+2.9%)
$888.00 K(+39.8%)
$2.84 M(-7.0%)
Sep 2020
-
$635.00 K(-2.2%)
$3.05 M(+15.2%)
Jun 2020
-
$649.00 K(-2.4%)
$2.65 M(-0.4%)
Mar 2020
-
$665.00 K(-39.5%)
$2.66 M(-3.6%)
Dec 2019
$2.76 M(+47.1%)
$1.10 M(+374.1%)
$2.76 M(+30.6%)
Sep 2019
-
$232.00 K(-64.8%)
$2.11 M(-16.8%)
Jun 2019
-
$659.00 K(-13.9%)
$2.54 M(+5.2%)
Mar 2019
-
$765.00 K(+68.5%)
$2.41 M(+28.7%)
Dec 2018
$1.87 M
$454.00 K(-31.1%)
$1.87 M(+9.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
$659.00 K(+23.4%)
$1.72 M(-3.8%)
Jun 2018
-
$534.00 K(+135.2%)
$1.79 M(+30.8%)
Mar 2018
-
$227.00 K(-24.3%)
$1.37 M(-22.1%)
Dec 2017
$1.75 M(-58.3%)
$300.00 K(-58.7%)
$1.75 M(-7.9%)
Sep 2017
-
$727.00 K(+543.4%)
$1.91 M(+41.0%)
Jun 2017
-
$113.00 K(-81.6%)
$1.35 M(-31.4%)
Mar 2017
-
$615.00 K(+36.7%)
$1.97 M(-53.2%)
Dec 2016
$4.21 M(-31.7%)
$450.00 K(+160.1%)
$4.21 M(-47.0%)
Sep 2016
-
$173.00 K(-76.4%)
$7.95 M(-10.7%)
Jun 2016
-
$732.00 K(-74.4%)
$8.90 M(+4.6%)
Mar 2016
-
$2.85 M(-31.9%)
$8.51 M(+38.0%)
Dec 2015
$6.17 M(+204.6%)
$4.19 M(+273.1%)
$6.17 M(+145.8%)
Sep 2015
-
$1.12 M(+229.3%)
$2.51 M(+27.2%)
Jun 2015
-
$341.00 K(-33.3%)
$1.97 M(-18.2%)
Mar 2015
-
$511.00 K(-4.1%)
$2.41 M(+19.1%)
Dec 2014
$2.02 M(+52.0%)
$533.00 K(-9.2%)
$2.02 M(+14.9%)
Sep 2014
-
$587.00 K(-24.7%)
$1.76 M(+36.1%)
Jun 2014
-
$780.00 K(+529.0%)
$1.29 M(+43.9%)
Mar 2014
-
$124.00 K(-54.2%)
$900.00 K(-32.4%)
Dec 2013
$1.33 M(-8.9%)
$271.00 K(+125.8%)
$1.33 M(+25.5%)
Sep 2013
-
$120.00 K(-68.8%)
$1.06 M(+12.8%)
Jun 2013
-
$385.00 K(-30.8%)
$941.00 K(+69.2%)
Mar 2013
-
$556.00 K
$556.00 K
Dec 2012
$1.46 M(+429.7%)
-
-
Dec 2011
$276.00 K
-
-

FAQ

  • What is Veracyte annual capital expenditures?
  • What is the all time high annual CAPEX for Veracyte?
  • What is Veracyte annual CAPEX year-on-year change?
  • What is Veracyte quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Veracyte?
  • What is Veracyte quarterly CAPEX year-on-year change?
  • What is Veracyte TTM capital expenditures?
  • What is the all time high TTM CAPEX for Veracyte?
  • What is Veracyte TTM CAPEX year-on-year change?

What is Veracyte annual capital expenditures?

The current annual CAPEX of VCYT is $9.96 M

What is the all time high annual CAPEX for Veracyte?

Veracyte all-time high annual capital expenditures is $9.96 M

What is Veracyte annual CAPEX year-on-year change?

Over the past year, VCYT annual capital expenditures has changed by +$1.41 M (+16.52%)

What is Veracyte quarterly capital expenditures?

The current quarterly CAPEX of VCYT is $2.24 M

What is the all time high quarterly CAPEX for Veracyte?

Veracyte all-time high quarterly capital expenditures is $4.19 M

What is Veracyte quarterly CAPEX year-on-year change?

Over the past year, VCYT quarterly capital expenditures has changed by -$255.00 K (-10.21%)

What is Veracyte TTM capital expenditures?

The current TTM CAPEX of VCYT is $9.64 M

What is the all time high TTM CAPEX for Veracyte?

Veracyte all-time high TTM capital expenditures is $11.10 M

What is Veracyte TTM CAPEX year-on-year change?

Over the past year, VCYT TTM capital expenditures has changed by -$318.00 K (-3.19%)